Your browser doesn't support javascript.
loading
Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
Edahiro, Yoko; Ochiai, Tomonori; Hashimoto, Yoshinori; Morishita, Soji; Shirane, Shuichi; Inano, Tadaaki; Furuya, Chiho; Koike, Michiaki; Noguchi, Masaaki; Usuki, Kensuke; Shiratsuchi, Motoaki; Nakajima, Kei; Ohtsuka, Eiichi; Tanaka, Hiroaki; Kawata, Eri; Nakamae, Mika; Ueda, Yasunori; Aota, Yasuo; Sugita, Yasumasa; Ohara, Shin; Yamasaki, Satoshi; Asagoe, Kohsuke; Yoshida, Shuro; Yamanouchi, Jun; Suzuki, Sayaka; Kondo, Toshinori; Kanisawa, Yuji; Toyama, Kohtaro; Omura, Hiromi; Mizuchi, Daisuke; Sakamaki, Sumio; Ando, Miki; Komatsu, Norio.
Afiliação
  • Edahiro Y; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-Ku, Tokyo, Japan. yedahiro@juntendo.ac.jp.
  • Ochiai T; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan. yedahiro@juntendo.ac.jp.
  • Hashimoto Y; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan. yedahiro@juntendo.ac.jp.
  • Morishita S; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-Ku, Tokyo, Japan.
  • Shirane S; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Inano T; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Furuya C; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-Ku, Tokyo, Japan.
  • Koike M; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan.
  • Noguchi M; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-Ku, Tokyo, Japan.
  • Usuki K; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Shiratsuchi M; Department of Advanced Hematology, Juntendo University Graduate School of Medicine, 2-1-1 Hongou, Bunkyo-Ku, Tokyo, Japan.
  • Nakajima K; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Ohtsuka E; Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Tanaka H; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Kawata E; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Nakamae M; Department of Hematology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
  • Ueda Y; Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan.
  • Aota Y; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Sugita Y; Department of Hematology, Iizuka Hospital, Iizuka, Japan.
  • Ohara S; Department of Hematology/Oncology, University of Yamanashi, Kofu, Japan.
  • Yamasaki S; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Asagoe K; Department of Hematology, Asahi General Hospital, Asahi, Japan.
  • Yoshida S; Department of Hematology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Yamanouchi J; Department of Hematology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
  • Suzuki S; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Kondo T; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Kanisawa Y; Department of Internal Medicine, Kohsei Chuo General Hospital, Tokyo, Japan.
  • Toyama K; Department of Hematology, Oami Municipal Hospital, Oamishirasato, Japan.
  • Omura H; Department of Hematology, Eiju General Hospital, Tokyo, Japan.
  • Mizuchi D; Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan.
  • Sakamaki S; Department of Hematology & Oncology, Shiga General Hospital, Moriyama, Japan.
  • Ando M; Department of Hematology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
  • Komatsu N; Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Toon, Japan.
Int J Hematol ; 118(1): 47-53, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37058247
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitose / Síndromes Mielodisplásicas / Doenças Mieloproliferativas-Mielodisplásicas / Anemia Sideroblástica / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitose / Síndromes Mielodisplásicas / Doenças Mieloproliferativas-Mielodisplásicas / Anemia Sideroblástica / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão